Altimmune say-on-pay fails; director Gill gets 41% withhold votes

Altimmune, Inc.

Say-on-pay proposal failed: 10.44M against vs 8.32M for, plus 9.68M broker non-votes.
Director John M. Gill reelected with 11.03M for and 7.78M withhold (41% of votes cast).
All other director nominees received >15M for votes; auditor Ernst & Young ratified with 28.43M for.
Adjournment proposal passed with 18.51M for, 9.79M against.
Approximately 72% of outstanding shares represented at the meeting, forming a quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.